MedCity News
MARCH 11, 2025
With $500 billion allocated to the Stargate initiative, just imagine what could be done if 10% of that focused on women, who make up 51% of the population. The post What If Part of the $500 Billion AI Allocation Was Focused On Womens Health? appeared first on MedCity News.
European Pharmaceutical Review
MARCH 11, 2025
Bristol Myers Squibb has agreed a merger with 2seventy bio in a deal worth approximately $286 million. A year ago, 2seventy decided to exclusively focus on unlocking the value of Abecma, with the goal of delivering more time for people living with multiple myeloma and maximizing value for all stakeholders, stated Chip Baird, Chief Executive Officer, 2seventy bio.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
MARCH 11, 2025
Multiple myeloma cell therapy Abecma is the lone remaining asset of 2seventy Bio, which spun out from Bluebird Bio in 2021. 2seventy and Bristol Myers Squibb currently share in U.S. commercialization of Abecma. The post Bristol Myers Squibb Buys Out Cancer Cell Therapy Partner 2seventy Bio in $286M Deal appeared first on MedCity News.
PharmaVoice
MARCH 11, 2025
Emalex Biosciences is full steam ahead with a targeted 2026 approval and launch for its novel drug.
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
MedCity News
MARCH 11, 2025
Abarca Health is paying attention to specialty drugs, AI in healthcare, the impact of obesity-related conditions, and increased government regulations. The post 4 Prescription Drug Trends that are Top of Mind for One Abarca Exec appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
MARCH 11, 2025
Many experts – be they venture capitalists or private equity investprs – shared their advice to biotech entrepreneurs navigating a tough funding envornment. The post How Can Startups Navigate the Difficult Funding Environment appeared first on MedCity News.
PharmaVoice
MARCH 11, 2025
An opaque system of rebates and discounts makes understanding a drug’s true price near impossible, even for experts. Can efforts to bring transparency into that system now pan out?
MedCity News
MARCH 11, 2025
As healthcare leaders look for the low-hanging fruit for AI and automation investments in the revenue cycle, there are three things that should be considered to achieve maximum impact on labor effectiveness. The post Revenue Cycle Automation: 3 Considerations For Optimal ROI appeared first on MedCity News.
PharmaTimes
MARCH 11, 2025
Oxford Medical Products targets overweight individuals
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
pharmaphorum
MARCH 11, 2025
Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286m
PharmaTimes
MARCH 11, 2025
CervoMed's therapy demonstrates significant improvement in patients
pharmaphorum
MARCH 11, 2025
Pfizer and Arvinas' much-anticipated oral SERD vepdegestrant for breast cancer missed a key endpoint in its first phase 3 readout
Pharmaceutical Technology
MARCH 11, 2025
AWSs framework will speed up the analysis of ElevateBios large protein datasets, hinting at promising drug candidates.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
pharmaphorum
MARCH 11, 2025
Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances
Pharmaceutical Technology
MARCH 11, 2025
The multi-year manufacturing deal with CordenPharma will secure future supply of VK2735 if it goes to market.
Pharmaceutical Commerce
MARCH 11, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Jason C. Foster, CEO of Ori Biotech, offers his perspective on the state of CGTs, along with their potential for transforming medicine.
Pharmaceutical Technology
MARCH 11, 2025
The deal comes after a challenging few years for 2seventy bio, which had divested research programmes in recent years.
Advertiser: ZoomInfo
In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.
Pharmaceutical Commerce
MARCH 11, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
MARCH 11, 2025
Lundbeck has gained ODD from Japans Ministry of Health, Labor and Welfare (MHLW) for amlenetug to treat multiple system atrophy (MSA).
PharmaTech
MARCH 11, 2025
The companys 100,000-sq.-ft. space is expected to enhance its capabilities for commercial oral dose treatment manufacturing in a variety of therapeutic areas.
Pharmaceutical Technology
MARCH 11, 2025
MSD has opened a $1bn facility in Durham located in the US state of North Carolina, to increase vaccine manufacturing capacity.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
PharmExec
MARCH 11, 2025
Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid increasing demand for GLP-1 therapy.
Pharmaceutical Technology
MARCH 11, 2025
The role of AI in supply chain management proved to be the focal issue at the recent 2025 Clinical Trial Supply Europe conference.
PharmExec
MARCH 11, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MARCH 11, 2025
Kenox and Lactiga US have announced a strategic partnership for progressing new mucosal-targeted sIgA therapies development.
Advertiser: ZoomInfo
As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.
PharmExec
MARCH 11, 2025
Results from multiple Phase III trials of Icotrokinra in moderate-to-severe plaque psoriasis and a Phase IIb trial in ulcerative colitis successfully met all primary endpoints.
PharmaTech
MARCH 11, 2025
Sterimove will make its North American debut at the April 13, 2025 event.
PharmExec
MARCH 11, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Expert insights. Personalized for you.
247 
Let's personalize your content